BioSpace News Archive

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will present at the H.C. Wainwright Global Life Sciences Conference which will be available on demand starting on March 9, 2021 at 7:00 am (ET)

AIDS Healthcare Foundation (AHF) praised today’s announcement from U.S. President Joseph R. Biden that pharmaceutical giant Merck will manufacture the vaccine from its competitor Johnson & Johnson in order to produce an additional 100 million doses, according to Politico (See: Merck to Help Produce Johnson & Johnson Vaccine, Politico 3/2/21).

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new data from the company’s HIV, hepatitis C virus (HCV), and COVID-19 research and development programs at the 28th Conference on Retroviruses and Opportunistic Infections (virtual CROI 2021) taking place from March 6-10

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced plans for the expansion of their Cell and Gene Therapy Center of Excellence in Milan, to increase capacities and implement viral vector suspension capabilities.

Forian Inc. announced that it has completed the combination of Helix Technologies, Inc. (OTCQB:HLIX) and Medical Outcomes Research Analytics, LLC.

Haemonetics Corporation (“Haemonetics”) (NYSE: HAE) today announced the pricing of its offering of $435,000,000 aggregate principal amount of 0.00% Convertible Senior Notes due 2026 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933,

CMAB Biopharma Inc congratulates its partner Innovent Biologics, Inc on the U.S. Food and Drug Administration clearance of an Investigational New Drug application for its antibody candidate which targets the COVID-19 virus, an independently-developed project by Innovent.

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today announced that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Global Life Sciences Conference

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, Steven Lo, will present a company overview at the H.C. Wainwright Global Life Sciences Conference

Walgreens Boots Alliance, Inc. will release its fiscal 2021 second quarter earnings results at 7 a.m. Eastern time, Wednesday, March 31, 2021 followed by a one-hour conference call with WBA management beginning at 8:30 a.m. Eastern time.